Previous Close | 13.85 |
Open | 13.91 |
Bid | 14.20 x 200 |
Ask | 14.33 x 100 |
Day's Range | 13.68 - 14.30 |
52 Week Range | 11.03 - 21.22 |
Volume | |
Avg. Volume | 906,712 |
Market Cap | 1.82B |
Beta (5Y Monthly) | 1.10 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.70 |
Earnings Date | Apr 30, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 21.55 |
Myriad (MYGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NeoGenomics (NEO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FT. MYERS, Fla., April 18, 2024--NeoGenomics, Inc., announced two promotions within its senior leadership team, effective immediately.